The people who will be old in 2040 are already alive. Why ageing is Singapore’s hardest structural problem and what is being done.
Startup · Topic
Healthcare, Biotech & Life Sciences
Expert guides, analysis and tool comparisons on Healthcare, Biotech & Life Sciences from the kurums.com Startup desk — written for business decision-makers and updated as the market moves.
- 5 guides
- Updated Aug 2, 2026
Latest in Healthcare, Biotech & Life Sciences
Singapore’s Medical Tourism: Losing the Volume, Keeping the Complexity
Regional hospitals caught up and Singapore got expensive. What remains of the medical travel business and why it still matters.
Singapore’s Healthcare Financing: How Co-Payment Became the Organising Principle
Singapore spends far less on healthcare than comparable countries. Here is how the layered financing model works and where the comparison misleads.
Biopolis and Singapore’s Biomedical Bet: What Industrial Policy Can and Cannot Buy
Singapore decided to build a biomedical industry and largely did. The manufacturing worked; the research commercialisation is a more honest story.
Parkway and IHH: How Singapore’s Private Hospitals Became Sovereign Assets
Singapore’s premium hospitals were won in a public bidding war by a foreign sovereign fund. Why healthcare attracts patient capital.
All guides
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.